2022
DOI: 10.1016/j.drugalcdep.2022.109376
|View full text |Cite
|
Sign up to set email alerts
|

Highlighting the hidden dangers of a ‘weak’ opioid: Deaths following use of dihydrocodeine in England (2001–2020)

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 26 publications
0
1
0
Order By: Relevance
“…Codeine may be placed on the second step on WHO analgesic ladder as a 'weak' opioid (Wojciech and Jaroslaw, 2016), and is being deployed as analgesic, antitussive, antidiarrheal, anti-cough and in opioid addiction (Rock et al, 2022). DHC administered orally have similar analgesic potency to codeine but twice as potent as tramadol (Leppert and Majkowicz, 2010).…”
Section: Introductionmentioning
confidence: 99%
“…Codeine may be placed on the second step on WHO analgesic ladder as a 'weak' opioid (Wojciech and Jaroslaw, 2016), and is being deployed as analgesic, antitussive, antidiarrheal, anti-cough and in opioid addiction (Rock et al, 2022). DHC administered orally have similar analgesic potency to codeine but twice as potent as tramadol (Leppert and Majkowicz, 2010).…”
Section: Introductionmentioning
confidence: 99%